Izidore S Lossos (Lzidore S Lossos)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 72

Top Topics

Epstein Barr Virus

Hodgkin Lymphoma

Top Venues

American journal of hematology

British journal of haematology

Expert review of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Jacob D Soumerai, Catherine S Diefenbach, Deepa Jagadeesh, Adam Asch, Abhijeet Kumar, Michaela L Tsai, Thomas A Jandl, Izidore S Lossos, Vaishalee P Kenkre, Farrukh T Awan, William Novotny, Jane Huang, Lu Miao, Prabhu Rajagopalan, Richard G Ghalie, Andrew D Zelenetz
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas. British journal of haematology 204 (5) (2024)
Allison M Bock, Raphael Mwangi, Yucai Wang, Arushi Khurana, Matthew John Maurer, Amy Ayers, Brad S Kahl, Peter Martin, Jonathon B Cohen, Carla Casulo, Izidore S Lossos, Umar Farooq, Sabarish Ayyappan, Tanner Reicks, Thomas M Habermann, Thomas E Witzig, Christopher R Flowers, James R Cerhan, Loretta J Nastoupil, Grzegorz S Nowakowski
Defining primary refractory large B-cell lymphoma. Blood advances 8 (13) (2024)
Kamilia N Moalem, Juan Pablo Alderuccio, Côme Bommier, Thomas Habermann, Brian L Link, James R Cerhan, Jorge Florindez, Izidore S Lossos
Transformation of marginal zone lymphoma to Hodgkin lymphoma. Blood advances 8 (17) (2024)
Iris Margalit Trutzer, Izidore S Lossos
Relapsed mantle cell lymphoma manifesting with soft tissue tumors of the extremities: University of Miami experience and review of the literatur. Annals of hematology (2024)
Allison M Bock, Raphael Mwangi, Yucai Wang, Arushi Khurana, Matthew John Maurer, Amy Ayers, Brad S Kahl, Peter Martin, Jonathon B Cohen, Carla Casulo, Izidore S Lossos, Umar Farooq, Sabarish Ayyappan, Tanner Reicks, Thomas M Habermann, Thomas E Witzig, Christopher R Flowers, James R Cerhan, Loretta J Nastoupil, Grzegorz S Nowakowski
Defining primary refractory large B-cell lymphoma. Blood advances 8 (13) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
Munevver Cinar, Lourdes Martinez-Medina, Pavan K Puvvula, Arsen Arakelyan, Badri N Vardarajan, Neil Anthony, Ganji P Nagaraju, Dongkyoo Park, Lei Feng, Faith Sheff, Marina Mosunjac, Debra Saxe, Steven Flygare, Olatunji B Alese, Jonathan L Kaufman, Sagar Lonial, Juan M Sarmiento, Izidore S Lossos, Paula M Vertino, Jose A Lopez, Bassel El-Rayes, Leon Bernal-Mizrachi
Transposon DNA sequences facilitate the tissue-specific gene transfer of circulating tumor DNA between human cells. Nucleic acids research 52 (13) (2024)
Jacob D Soumerai, Catherine S Diefenbach, Deepa Jagadeesh, Adam Asch, Abhijeet Kumar, Michaela L Tsai, Thomas A Jandl, Izidore S Lossos, Vaishalee P Kenkre, Farrukh T Awan, William Novotny, Jane Huang, Lu Miao, Prabhu Rajagopalan, Richard G Ghalie, Andrew D Zelenetz
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas. British journal of haematology 204 (5) (2024)
Brooj Abro, Matthew John Maurer, Thomas M Habermann, W Richard Burack, Jennifer R Chapman, Jonathon B Cohen, Jonathan W Friedberg, Giorgio Ga Inghirami, Brad S Kahl, Melissa C Larson, Brian L Link, Izidore S Lossos, Peter Martin, Timothy McDonnell, Loretta J Nastoupil, Shaun Riska, Sergei I Syrbu, Francisco Vega, Kiran Vij, Christopher R Flowers, James R Cerhan, David L Jaye, Andrew L Feldman
Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO Cohort Study analysis. Blood (2024)
Jorge Florindez, Dai Chihara, Isildinha Reis, Izidore S Lossos, Juan Pablo Alderuccio
Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US Population-based Analysis. Blood advances (2024)
Kamilia N Moalem, Juan Pablo Alderuccio, Côme Bommier, Thomas Habermann, Brian L Link, James R Cerhan, Jorge Florindez, Izidore S Lossos
Transformation of marginal zone lymphoma to Hodgkin lymphoma. Blood advances 8 (17) (2024)
Kamilia N Moalem, Juan Pablo Alderuccio, Côme Bommier, Thomas H Habermann, Brian L Link, James R Cerhan, Jorge Antenor Florindez, Izidore S Lossos
Transformation of Marginal Zone Lymphoma to Hodgkin Lymphoma. Blood advances (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology (2024)
Arushi Khurana, Raphael Mwangi, Loretta J Nastoupil, Patrick M Reagan, Umar Farooq, Jason T Romancik, Timothy McDonnell, Shaun Riska, Izidore S Lossos, Brad S Kahl, Peter Martin, Thomas E Witzig, James R Cerhan, Christopher R Flowers, Grzegorz S Nowakowski, Matthew John Maurer
Evaluating Lab-Based Eligibility Criteria by Race/Ethnicity in Clinical Trials of Diffuse Large B-Cell Lymphoma. Blood advances (2024)
Jacob D Soumerai, Catherine S Diefenbach, Deepa Jagadeesh, Adam Asch, Abhijeet Kumar, Michaela L Tsai, Thomas A Jandl, Izidore S Lossos, Vaishalee P Kenkre, Farrukh T Awan, William Novotny, Jane Huang, Lu Miao, Prabhu Rajagopalan, Richard G Ghalie, Andrew D Zelenetz
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas. British journal of haematology 204 (5) (2024)
Arushi Khurana, Raphael Mwangi, Loretta J Nastoupil, Patrick M Reagan, Umar Farooq, Jason T Romancik, Timothy J McDonnell, Shaun M Riska, Izidore S Lossos, Brad S Kahl, Peter Martin, Thomas E Witzig, James R Cerhan, Christopher R Flowers, Grzegorz S Nowakowski, Matthew John Maurer
Evaluating the impact of laboratory-based eligibility criteria by race/ethnicity in first-line clinical trials of DLBCL. Blood advances 8 (16) (2024)
Jorge A Florindez, Dai Chihara, Isildinha M Reis, Izidore S Lossos, Juan Pablo Alderuccio
Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US population-based analysis. Blood advances 8 (16) (2024)
Jacob D Soumerai, Catherine S Diefenbach, Deepa Jagadeesh, Adam Asch, Abhijeet Kumar, Michaela L Tsai, Thomas A Jandl, Izidore S Lossos, Vaishalee P Kenkre, Farrukh T Awan, William Novotny, Jane Huang, Lu Miao, Prabhu Rajagopalan, Richard G Ghalie, Andrew D Zelenetz
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas. British journal of haematology 204 (5) (2024)
Allison M Bock, Raphael Mwangi, Yucai Wang, Arushi Khurana, Matthew John Maurer, Amy Ayers, Brad S Kahl, Peter Martin, Jonathon B Cohen, Carla Casulo, Izidore S Lossos, Umar Farooq, Sabarish Ayyappan, Tanner Wayne Reicks, Thomas M Habermann, Thomas E Witzig, Christopher R Flowers, James R Cerhan, Loretta J Nastoupil, Grzegorz S Nowakowski
Defining Primary Refractory Large B-cell Lymphoma. Blood advances (2024)
Munevver Cinar, Lourdes Martinez-Medina, Pavan K Puvvula, Arsen Arakelyan, Badri N Vardarajan, Neil Anthony, Ganji P Nagaraju, Dongkyoo Park, Lei Feng, Faith Sheff, Marina Mosunjac, Debra Saxe, Steven Flygare, Olatunji B Alese, Jonathan L Kaufman, Sagar Lonial, Juan M Sarmiento, Izidore S Lossos, Paula M Vertino, Jose A Lopez, Bassel El-Rayes, Leon Bernal-Mizrachi
Transposon DNA sequences facilitate the tissue-specific gene transfer of circulating tumor DNA between human cells. Nucleic acids research (2024)
Jacob D Soumerai, Catherine S Diefenbach, Deepa Jagadeesh, Adam Asch, Abhijeet Kumar, Michaela L Tsai, Thomas A Jandl, Izidore S Lossos, Vaishalee P Kenkre, Farrukh T Awan, William Novotny, Jane Huang, Lu Miao, Prabhu Rajagopalan, Richard G Ghalie, Andrew D Zelenetz
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas. British journal of haematology (2024)
Jacob D Soumerai, Catherine S Diefenbach, Deepa Jagadeesh, Adam Asch, Abhijeet Kumar, Michaela L Tsai, Thomas A Jandl, Izidore S Lossos, Vaishalee P Kenkre, Farrukh T Awan, William Novotny, Jane Huang, Lu Miao, Prabhu Rajagopalan, Richard G Ghalie, Andrew D Zelenetz
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas. British journal of haematology 204 (5) (2024)
Munevver Cinar, Lourdes Martinez-Medina, Pavan K Puvvula, Arsen Arakelyan, Badri N Vardarajan, Neil Anthony, Ganji P Nagaraju, Dongkyoo Park, Lei Feng, Faith Sheff, Marina Mosunjac, Debra Saxe, Steven Flygare, Olatunji B Alese, Jonathan L Kaufman, Sagar Lonial, Juan M Sarmiento, Izidore S Lossos, Paula M Vertino, Jose A Lopez, Bassel El-Rayes, Leon Bernal-Mizrachi
Transposon DNA sequences facilitate the tissue-specific gene transfer of circulating tumor DNA between human cells. Nucleic acids research 52 (13) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
Tycel Jovelle Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S Lossos, Pier Luigi Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Ping Jiang, Peter W M Johnson
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204). Blood advances 8 (4) (2024)
James R Cerhan, Matthew John Maurer, Brian L Link, Andrew L Feldman, Thomas M Habermann, David L Jaye, W Richard Burack, Timothy J McDonnell, Francisco Vega, Jennifer R Chapman, Sergei Syrbu, Kiran R Vij, Giorgio Inghirami, John P Leonard, Leon Bernal-Mizrachi, Umar Farooq, Thomas E Witzig, George J Weiner, Yucai Wang, Juan Pablo Alderuccio, Susan L Slager, Melissa C Larson, Shaun M Riska, Brianna J Gysbers, Julianne J Lunde, Tanner W Reicks, Amy A Ayers, Colin B O'Leary, Kathleen J Yost, Hongfang Liu, Grzegorz S Nowakowski, Jia Ruan, Dai Chihara, Jean L Koff, Carla Casulo, Carrie A Thompson, Jonathon B Cohen, Brad S Kahl, Loretta J Nastoupil, Izidore S Lossos, Jonathan W Friedberg, Peter Martin, Christopher R Flowers
The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes. American journal of hematology 99 (3) (2024)
Allison M Bock, Raphael Mwangi, Yucai Wang, Arushi Khurana, Matthew John Maurer, Amy Ayers, Brad S Kahl, Peter Martin, Jonathon B Cohen, Carla Casulo, Izidore S Lossos, Umar Farooq, Sabarish Ayyappan, Tanner Reicks, Thomas M Habermann, Thomas E Witzig, Christopher R Flowers, James R Cerhan, Loretta J Nastoupil, Grzegorz S Nowakowski
Defining primary refractory large B-cell lymphoma. Blood advances 8 (13) (2024)
Tycel Jovelle Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S Lossos, Pier Luigi Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Ping Jiang, Peter W M Johnson
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204). Blood advances 8 (4) (2024)
Juan Pablo Alderuccio, Izidore S Lossos
Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma. Expert review of hematology 16 (5) (2023)
Tycel Jovelle Phillips, Abraham Avigdor, Ronit Gurion, Caterina Patti, Paolo Corradini, Monica Tani, Amitkumar Mehta, Izidore S Lossos, Pier Luigi Luigi Zinzani, Catherine Thieblemont, Wojciech Jurczak, Fred Zheng, Erica Rappold, Wanying Zhao, Ping Jiang, Peter W M Johnson
A phase 2 study of the PI3Kδ inhibitor parsaclisib in relapsed and refractory marginal zone lymphoma (CITADEL-204). Blood advances (2023)
Juan Pablo Alderuccio, Isildinha M Reis, Mehdi Hamadani, Muthiah Nachiappan, Salman Leslom, Brad S Kahl, Weiyun Z Ai, John Radford, Melham M Solh, Kirit M Ardeshna, Brian T Hess, Matthew A Lunning, Pier Luigi Luigi Zinzani, Anastasios Stathis, Carmello Carlo-Stella, Izidore S Lossos, Paolo F Caimi, Sunwoo Han, Fei Yang, Russ A Kuker, Craig H Moskowitz
PET/CT-biomarkers enable risk stratification of patients with relapsed/refractory diffuse large B-cell lymphoma enrolled in the LOTIS-2 clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
L Elizabeth Elizabeth Budde, Adam J Olszewski, Sarit Assouline, Izidore S Lossos, Catherine Diefenbach, Manali Kamdar, Nilanjan Ghosh, Dipenkumar Modi, Waleed Sabry, Seema Naik, Amitkumar Mehta, Shazia K Nakhoda, Stephen D Smith, Kathleen Dorritie, Ting Jia, Song Pham, Ling-Yuh Huw, Jing Jing, Hao Wu, Wahib S Ead, Iris To, Connie Lee Batlevi, Michael C Wei, Julio C Chavez
Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large B cell lymphoma: a phase 1b/2 trial. Nature medicine (2023)
Raphael E Steiner, Steven R Hwang, Arushi Khurana, Thomas M Habermann, Narendranath Epperla, Kaitlin Annunzio, Pamela Blair Allen, Katelin Baird, Darina Paulino, Juan Pablo Alderuccio, Izidore S Lossos, Kevin A David, Andrew M Evens, Karan Pandya, Steven M Bair, Manali Kamdar, Sheeba H Ba Aqeel, Pallawi Torka, Ryan C Lynch, Stephen Douglas Smith, Lei Feng, Mansoor Noorani, Sairah A Ahmed, Ranjit Nair, Francisco Vega, Susan Wu, Penny Q Fang, Chelsea C Pinnix, Jillian R Gunther, Bouthaina S Dabaja, Jee Hun Lee
Impact of Cumulative Dose of Brentuximab Vedotin on Outcomes of Frontline Therapy for Advanced Stage Hodgkin Lymphoma. Blood advances (2023)
Juan Pablo Alderuccio, Isildinha M Reis, Jean L Koff, Melissa C Larson, Dai Chihara, Wei Zhao, Sara Haddadi, Thomas M Habermann, Peter Martin, Jennifer Chapman, Christopher S Strouse, Brad S Kahl, Jonathon B Cohen, Jonathan W Friedberg, James R Cerhan, Christopher R Flowers, Izidore S Lossos
Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma. Blood (2023)
Juan Pablo Alderuccio, Izidore S Lossos
Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma. Expert review of hematology (2023)
Juan Pablo Alderuccio, Izidore S Lossos
Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma. Expert review of hematology (2023)
Adam J Olszewski, Tycel Jovelle Phillips, Marc S Hoffmann, Philippe Armand, Tae Min Kim, Dok Hyun Yoon, Amitkumar Mehta, Richard Greil, Jason R Westin, Izidore S Lossos, Javier L Muñoz, Jason Sit, Michael C Wei, Annie Yang, Vivian Chen, Enkhtsetseg Purev, Donald L Yee, Ulrich Jäger
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study. Blood advances (2023)
Juan Pablo Alderuccio, Izidore S Lossos
Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma. Expert review of hematology 16 (5) (2023)
Juan Pablo Alderuccio, Izidore S Lossos
Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma. Expert review of hematology 16 (5) (2023)
David A Russler-Germain, Kilannin Krysiak, Cody A Ramirez, Matthew Mosior, Marcus P Watkins, Felicia Gomez, Zachary L Skidmore, Lee Trani, Feng Gao, Susan Geyer, Amanda F Cashen, Neha Mehta-Shah, Brad S Kahl, Nancy L Bartlett, Juan Pablo Alderuccio, Izidore S Lossos, Sarah L Ondrejka, Eric D Hsi, Peter Martin, John P Leonard, Malachi Griffith, Malachi Griffith, Todd A Fehniger
Mutations Associated with Progression in Follicular Lymphoma Predict Inferior Outcomes at Diagnosis (Alliance A151303). Blood advances (2023)
Juan Pablo Alderuccio, Izidore S Lossos
Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma. Expert review of hematology 16 (5) (2023)
Juan Pablo Alderuccio, Izidore S Lossos
Enhancing prognostication and personalizing treatment of extranodal marginal zone lymphoma. Expert review of hematology 16 (5) (2023)
Juan Pablo Alderuccio, Isildinha M Reis, Jean L Koff, Melissa C Larson, Dai Chihara, Wei Zhao, Sara Haddadi, Thomas M Habermann, Peter Martin, Jennifer Chapman, Christopher S Strouse, Brad S Kahl, Jonathon B Cohen, Jonathan W Friedberg, James R Cerhan, Christopher R Flowers, Izidore S Lossos
Predictive value of staging PET/CT to detect bone marrow involvement and early outcomes in marginal zone lymphoma. Blood (2023)
R Andrew Harkins, Sharvil Piyush Patel, Michelle J Lee, Jeffrey M Switchenko, Stephen M Ansell, Nancy L Bartlett, Kristie A Blum, Amanda F Cashen, Carla Casulo, Jonathan W Friedberg, Patrick B Johnston, Brad S Kahl, John P Leonard, Brian L Link, Izidore S Lossos, Peter Martin, Matthew John Maurer, Neha Mehta-Shah, Patrick M Reagan, Jason R Westin, Jean L Koff, Christopher R Flowers
Improving eligibility criteria for first-line trials for patients with DLBCL using a US-based Delphi-method survey. Blood advances 6 (9) (2022)
Eduardo Edelman Saul, Juan Pablo Alderuccio, Isildinha M Reis, Wei Zhao, Sunil Girish Iyer, Gregor Rodriguez, Amrita Desai, Jennifer R Chapman, David T Tse, Arnold M Markoe, Derek M Isrow, Izidore S Lossos
Long-term outcomes of patients with conjunctival extranodal marginal zone lymphoma. American journal of hematology (2022)
Juan Pablo Alderuccio, Luca Arcaini, Marcus P Watkins, Anne W Beaven, Geoffrey Shouse, Narendranath Epperla, Michele Spina, Alexandra Stefanovic, Jose Sandoval-Sus, Pallawi Torka, Ash B Alpert, Adam J Olszewski, Seo-Hyun Kim, Brian Hess, Sameh Gaballa, Sabarish Ayyappan, Jorge J Castillo, Lisa Argnani, Timothy J Voorhees, Raya Saba, Sayan Mullick Chowdhury, Fernando Vargas, Isildinha M Reis, Deukwoo Kwon, Jonathan Struan Alexander, Wei Zhao, Dali Edwards, Peter Martin, Emanuele Cencini, Manali Kamdar, Brian L Link, Constantine N Logothetis, Alex F Herrera, Jonathan W Friedberg, Brad S Kahl, Stefano Luminari, Pier Luigi Luigi Zinzani, Izidore S Lossos
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma. Blood advances 6 (7) (2022)
Juan Pablo Alderuccio, Isildinha M Reis, Thomas M Habermann, Brian K Link, Catherine Thieblemont, Annarita Conconi, Melissa C Larson, Luciano Cascione, Wei Zhao, James R Cerhan, Emanuele Zucca, Izidore S Lossos
Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma. American journal of hematology 97 (12) (2022)
Danny Luan, Tolulope Fatola, Ahmed Toure, Christopher R Flowers, Brian L Link, Jonathan W Friedberg, Jonathon B Cohen, Brad S Kahl, Izidore S Lossos, Loretta Nastoupil, Matthew John Maurer, James R Cerhan, Peter Martin
Evaluating the impact of eligibility criteria in first-line clinical trials for follicular lymphoma: a MER/LEO cohort analysis. Blood advances 6 (15) (2022)
Kerri-Ann Latchmansingh, Xiaoqiong Wang, Ramiro E Verdun, Mario L Marques-Piubelli, Francisco Vega, M James You, Jennifer Chapman, Izidore S Lossos
LMO2 expression is frequent in T-lymphoblastic leukemia and correlates with survival, regardless of T-cell stage. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 35 (9) (2022)
Xiaoyu Jiang, XiaoQing Lu, Andrew J Gentles, Dekuang Zhao, Seth A Wander, Yu Zhang, Yasodha Natkunam, Joyce Slingerland, Isildinha M Reis, Brian Rabinovich, Midhat H Abdulreda, Vincent T Moy, Izidore S Lossos
HGAL inhibits lymphoma dissemination by interacting with multiple cytoskeletal proteins. Blood advances 5 (23) (2022)
Juan Pablo Alderuccio, Thomas M Habermann, Russ Kuker, Craig H Moskowitz, Andrew D Zelenetz, Izidore S Lossos
A roadmap for clinical trial design in marginal zone lymphoma. American journal of hematology 97 (11) (2022)
Paolo Strati, Morton Coleman, Rebecca Champion, Shuo Ma, Caterina Patti, Moshe Y Levy, Izidore S Lossos, Praveen Ramakrishnan Geethakumari, Selay Lam, Roser Calvo, Kara Higgins, L Elizabeth Elizabeth Budde
A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma. British journal of haematology 199 (1) (2022)
Anas Younes, John M Burke, Bruce D Cheson, Catherine Diefenbach, Silvia Ferrari, Uwe Hahn, Eliza A Hawkes, Cyrus Khan, Izidore S Lossos, Gerardo Musuraca, Monica Tani, Umberto Vitolo, Sam L S Yuen, Aparna Raval, Mahesh Shivhare, Tina G Nielsen, Gila Sellam, Jeff P Sharman
Safety and efficacy of atezolizumab with rituximab and CHOP in previously untreated diffuse large B-cell lymphoma. Blood advances (2022)
Russ A Kuker, David Lehmkuhl, Deukwoo Kwon, Weizhao Zhao, Izidore S Lossos, Craig H Moskowitz, Juan Pablo Alderuccio, Fei Yang
A Deep Learning-Aided Automated Method for Calculating Metabolic Tumor Volume in Diffuse Large B-Cell Lymphoma. Cancers 14 (21) (2022)
Juan Pablo Alderuccio, Adam J Olszewski, Andrew M Evens, Graham P Collins, Alexey V Danilov, Mark Bower, Deepa Jagadeesh, Catherine Zhu, Amy Sperling, Seo-Hyun Kim, Ryan Vaca, Catherine Wei, Suchitra Sundaram, Nishitha Reddy, Alessia Dalla Pria, Christopher R D'Angelo, Umar Farooq, David A Bond, Stephanie Berg, Michael C Churnetski, Amandeep Godara, Nadia Khan, Yun Kyong Choi, Shireen Kassam, Maryam Sarraf Yazdy, Emma Rabinovich, Frank A Post, Gaurav Varma, Reem Karmali, Madelyn Burkart, Peter Martin, Albert Ren, Ayushi Chauhan, Catherine S Diefenbach, Allandria Straker-Edwards, Andreas Klein, Kristie A Blum, Kirsten Marie Boughan, Agrima Mian, Bradley M Haverkos, Victor M Orellana-Noia, Vaishalee P Kenkre, Adam Stephen Zayac, Seth M Maliske, Narendranath Epperla, Paolo Caimi, Scott E Smith, Manali Kamdar, Parameswaran Venugopal, Tatyana A Feldman, Daniel Rector, Stephen Douglas Smith, Andrzej Stadnik, Craig A Portell, Yong Lin, Seema G Naik, Silvia Montoto, Izidore S Lossos, Kate Cwynarski
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis. Blood advances 5 (14) (2021)
Georgios N Pongas, Juan Pablo Alderuccio, Jennifer R Chapman, Izidore S Lossos
Mantle cell lymphoma involving the thyroid gland. Clinical case reports 9 (9) (2021)
Judith Trotman, Nilanjan Ghosh, Izidore S Lossos, Maria Lia Palomba, Amitkumar Mehta, Olivier Casasnovas, Don Stevens, Sudhakar Katakam, Andrea Knapp, Tina Nielsen, Ron McCord, Gilles Andre Salles
Obinutuzumab-atezolizumab-lenalidomide for the treatment of patients with relapsed/refractory follicular lymphoma: final analysis of a Phase Ib/II trial. Blood cancer journal 11 (8) (2021)
Adam J Olszewski, Lasse Hjort Kyneb Jakobsen, Graham P Collins, Kate Cwynarski, Veronika Bachanova, Kristie A Blum, Kirsten M Boughan, Mark Bower, Alessia Dalla Pria, Alexey Danilov, Kevin A David, Catherine S Diefenbach, Fredrik Ellin, Narendranath Epperla, Umar Farooq, Tatyana A Feldman, Alina S Gerrie, Deepa Jagadeesh, Manali Kamdar, Reem Karmali, Shireen Kassam, Vaishalee P Kenkre, Nadia Khan, Seo-Hyun Kim, Andreas K Klein, Izidore S Lossos, Matthew A Lunning, Peter Martin, Nicolás Martinez-Calle, Silvia Montoto, Seema Naik, Neil Palmisiano, David J Peace, Elizabeth H Phillips, Tycel Jovelle Phillips, Craig A Portell, Nishitha M Reddy, Anna Santarsieri, Maryam Sarraf Yazdy, Knut B Smeland, Scott E Smith, Stephen Douglas Smith, Suchitra Sundaram, Adam Stephen Zayac, Xiao-Yin Zhang, Catherine Zhu, Chan Yoon Y Cheah, Tarec C El-Galaly, Andrew M Evens
Burkitt Lymphoma International Prognostic Index. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (10) (2021)
Sunil Girish Iyer, Russ A Kuker, Jorge A Florindez, Eduardo Edelman Saul, Asaad Trabolsi, Gregor Rodriguez, Jennifer R Chapman, Izidore S Lossos, Juan Pablo Alderuccio
A single-center analysis of patients with extranodal marginal zone lymphoma of the breast. Leukemia & lymphoma (2021)
Asaad Trabolsi, Juan Pablo Alderuccio, Jorge Florindez, Gregor Rodriguez, Eduardo Saul, Sunil Girish Iyer, Jennifer R Chapman, Julio Poveda, Daniel A Sussman, Izidore S Lossos
Marginal zone lymphoma of the colon: case series from a single center and SEER data review. Leukemia & lymphoma 63 (5) (2021)
Juan Pablo Alderuccio, Eduardo E Saul, Sunil Girish Iyer, Isildinha M Reis, Alvaro J Alencar, Joseph D Rosenblatt, Izidore S Lossos
R-MACLO-IVAM regimen followed by maintenance therapy induces durable remissions in untreated mantle cell lymphoma - Long term follow up results. American journal of hematology 96 (6) (2021)
Xiaoyu Jiang, Xiaoqing Lu, Yu Zhang, Leda Lacaria, Brett J Schuchardt, David C Mikles, Marco Magistri, Idoia García-Ramírez, Isidro Sanchez-Garcia, Amjad Farooq, Ramiro E Verdun, Midhat H Abdulreda, Vincent T Moy, Izidore S Lossos
Interplay between HGAL and Grb2 proteins regulates B-cell receptor signaling. Blood advances 3 (15) (2020)
John Timmerman, Charles Herbaux, Vincent Ribrag, Andrew D Zelenetz, Roch Houot, Sattva S Neelapu, Theodore Logan, Izidore S Lossos, Walter Urba, Gilles Salles, Radhakrishnan Ramchandren, Caron Jacobson, John Godwin, Cecilia Carpio, Deanne Lathers, Yali Liu, Jaclyn Neely, Satyendra Suryawanshi, Yoshinobu Koguchi, Ronald Levy
Urelumab alone or in combination with rituximab in patients with relapsed or refractory B-cell lymphoma. American journal of hematology 95 (5) (2020)
Muhammad Husnain, Russ Kuker, Isildinha M Reis, Sunil Girish Iyer, Wei Zhao, Jennifer R Chapman, Francisco Vega, Izidore S Lossos, Juan Pablo Alderuccio
Clinical and radiological characteristics of patients with pulmonary marginal zone lymphoma: A single center analysis. Cancer medicine 9 (14) (2020)
Jorge A Florindez, Juan Pablo Alderuccio, Isildinha M Reis, Izidore S Lossos
Splenic marginal zone lymphoma: A US population-based survival analysis (1999-2016). Cancer 126 (21) (2020)
Juan Pablo Alderuccio, Wei Zhao, Amrita Desai, Jeremy Ramdial, Nicolas Gallastegui, Erik Kimble, Macarena Ines de la Fuente, Muhammad Husnain, Joseph D Rosenblatt, Alvaro J Alencar, Jonathan H Schatz, Craig H Moskowitz, Jennifer R Chapman, Francisco Vega, Isildinha M Reis, Izidore S Lossos
Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation. American journal of hematology 94 (5) (2019)
Macarena Ines de la Fuente, Juan Pablo Alderuccio, Isildinha M Reis, Antonio Omuro, Arnold Markoe, Jose J Echegaray, Janet L Davis, J William Harbour, Izidore S Lossos
Bilateral radiation therapy followed by methotrexate-based chemotherapy for primary vitreoretinal lymphoma. American journal of hematology 94 (4) (2019)
Fengjie Guo, Yuan Luo, Xiaoyu Jiang, XiaoQing Lu, Domenico Roberti, Chen Lossos, Kranthi Kunkalla, Marco Magistri, Lixin Rui, Ramiro Verdun, Francisco Vega, Vincent T Moy, Izidore S Lossos
Recent BCR stimulation induces a negative autoregulatory loop via FBXO10 mediated degradation of HGAL. Leukemia 34 (2) (2019)
Macarena Ines de la Fuente, Juan Pablo Alderuccio, Izidore S Lossos
Central nervous system emergencies in haematological malignancies. British journal of haematology 189 (6) (2019)
Xiaoqing Lu, Tharu M Fernando, Chen Lossos, Nevin Yusufova, Fan Liu, Lorena Fontán, Matthew Durant, Huimin Geng, Jacob Melnick, Yuan Luo, Francisco Vega, Vincent Moy, Giorgio Inghirami, Stephen Nimer, Ari M Melnick, Izidore S Lossos
PRMT5 interacts with the BCL6 oncoprotein and is required for germinal center formation and lymphoma cell survival. Blood 132 (19) (2018)